Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients

Previous studies have shown that n-3 polyunsaturated fatty acids n-3 (n-3 PUFA) have several anticancer effects, especially attributed to their ability to modulate a variety of genomic and immune responses. In this context, this randomized, prospective, controlled clinical trial was conducted in ord...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lipids 2013-09, Vol.48 (9), p.879-888
Hauptverfasser: Mocellin, Michel Carlos, Pastore e Silva, Juliana de Aguiar, Camargo, Carolina de Quadros, Fabre, Maria Emília de Souza, Gevaerd, Scheila, Naliwaiko, Katya, Moreno, Yara Maria Franco, Nunes, Everson Araújo, Trindade, Erasmo Benicio Santos de Moraes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 888
container_issue 9
container_start_page 879
container_title Lipids
container_volume 48
creator Mocellin, Michel Carlos
Pastore e Silva, Juliana de Aguiar
Camargo, Carolina de Quadros
Fabre, Maria Emília de Souza
Gevaerd, Scheila
Naliwaiko, Katya
Moreno, Yara Maria Franco
Nunes, Everson Araújo
Trindade, Erasmo Benicio Santos de Moraes
description Previous studies have shown that n-3 polyunsaturated fatty acids n-3 (n-3 PUFA) have several anticancer effects, especially attributed to their ability to modulate a variety of genomic and immune responses. In this context, this randomized, prospective, controlled clinical trial was conducted in order to check whether supplementation of 2 g/day of fish oil for 9 weeks alters the production of inflammatory markers, the plasma fatty acid profile and the nutritional status in patients with colorectal cancer (CRC). Eleven adults with CRC in chemotherapy were randomized into two groups: (a) supplemented (SG) daily with 2 g/day of encapsulated fish oil [providing 600 mg/day of eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)] for 9 weeks ( n  = 6), and (b) control (CG) ( n  = 5). All outcomes were evaluated on the day before the first chemotherapy session and 9 weeks later. Plasma TNF-α, IL-1β, IL-10 and IL-17A, the pro/anti-inflammatory balance (ratio TNF-α/IL-10 and IL-1β/IL10) and serum albumin, showed no significant changes between times and study groups ( p  > 0.05). C-reactive protein (CRP) and the CRP/albumin ratio showed opposite behavior in groups, significantly reducing their values in SG ( p  
doi_str_mv 10.1007/s11745-013-3816-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1458537570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3050043621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4539-c4289f256914271319de1aa43a1a1dd8f68ff6308ff3bf089c7be927201043963</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EokvhAbggS1y4hHpiJ7aPq5SFlVZ0VcHZ8iaTxVXiFDtptU_RV66jFISQEJexbH__r5n5CXkL7CMwJi8igBRFxoBnXEGZsWdkBUWhMs2ZfE5WjOUiEzmDM_Iqxpt0BaGLl-Qs50opDnJFHjYu_qBXrqOXWAe0ESOtsmu09ejukO7DMKLzF-vuMPXO02s7uoFu-9sw3Dl_pF-nMbj05G03s0c_RBep9Q3ddzb2lm7sOJ7ounbN_N-6DmmyqYZuCFiPSVVZX2Og-2SMfoyvyYvWdhHfPJ3n5Pvm07fqS7a7-ryt1rusFgXXqeZKt3lRahC5BA66QbBWcAsWmka1pWrbkrNU-aFlStfygDqXaRdMcF3yc_Jh8U2T_JwwjqZ3scausx6HKRoQhSq4LCRL6Pu_0JthCmnimcpLobniPFGwUHUYYgzYmtvgehtOBpiZ0zJLWialZea0zOz87sl5OvTY_Fb8iicBcgHu0-JO_3c0u-3-kimpkzJflDGJ_BHDH03_s59HOV-vhA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1426493833</pqid></control><display><type>article</type><title>Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>SpringerLink Journals - AutoHoldings</source><creator>Mocellin, Michel Carlos ; Pastore e Silva, Juliana de Aguiar ; Camargo, Carolina de Quadros ; Fabre, Maria Emília de Souza ; Gevaerd, Scheila ; Naliwaiko, Katya ; Moreno, Yara Maria Franco ; Nunes, Everson Araújo ; Trindade, Erasmo Benicio Santos de Moraes</creator><creatorcontrib>Mocellin, Michel Carlos ; Pastore e Silva, Juliana de Aguiar ; Camargo, Carolina de Quadros ; Fabre, Maria Emília de Souza ; Gevaerd, Scheila ; Naliwaiko, Katya ; Moreno, Yara Maria Franco ; Nunes, Everson Araújo ; Trindade, Erasmo Benicio Santos de Moraes</creatorcontrib><description>Previous studies have shown that n-3 polyunsaturated fatty acids n-3 (n-3 PUFA) have several anticancer effects, especially attributed to their ability to modulate a variety of genomic and immune responses. In this context, this randomized, prospective, controlled clinical trial was conducted in order to check whether supplementation of 2 g/day of fish oil for 9 weeks alters the production of inflammatory markers, the plasma fatty acid profile and the nutritional status in patients with colorectal cancer (CRC). Eleven adults with CRC in chemotherapy were randomized into two groups: (a) supplemented (SG) daily with 2 g/day of encapsulated fish oil [providing 600 mg/day of eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)] for 9 weeks ( n  = 6), and (b) control (CG) ( n  = 5). All outcomes were evaluated on the day before the first chemotherapy session and 9 weeks later. Plasma TNF-α, IL-1β, IL-10 and IL-17A, the pro/anti-inflammatory balance (ratio TNF-α/IL-10 and IL-1β/IL10) and serum albumin, showed no significant changes between times and study groups ( p  &gt; 0.05). C-reactive protein (CRP) and the CRP/albumin ratio showed opposite behavior in groups, significantly reducing their values in SG ( p  &lt; 0.05). Plasma proportions of EPA and DHA increased 1.8 and 1.4 times, respectively, while the ARA reduced approximately 0.6 times with the supplementation (9 weeks vs baseline, p  &lt; 0.05). Patients from SG gained 1.2 kg (median) while the CG lost −0.5 kg (median) during the 9 weeks of chemotherapy ( p  = 0.72). These results demonstrate that 2 g/day of fish oil for 9 weeks of chemotherapy improves CRP values, CRP/albumin status, plasma fatty acid profile and potentially prevents weight loss during treatment.</description><identifier>ISSN: 0024-4201</identifier><identifier>EISSN: 1558-9307</identifier><identifier>DOI: 10.1007/s11745-013-3816-0</identifier><identifier>PMID: 23888317</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Animals ; Biomedical and Life Sciences ; Body Mass Index ; C-Reactive Protein - metabolism ; Chemotherapy ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - blood ; Colorectal Neoplasms - drug therapy ; Cytokines ; Dietary Supplements ; Docosahexaenoic Acids - administration &amp; dosage ; Docosahexaenoic Acids - blood ; Docosahexaenoic Acids - therapeutic use ; Drug Administration Schedule ; Eicosapentaenoic Acid - administration &amp; dosage ; Eicosapentaenoic Acid - blood ; Eicosapentaenoic Acid - therapeutic use ; Fatty acid profile ; Fatty Acids - blood ; Female ; Fish oil ; Fish oils ; Fish Oils - administration &amp; dosage ; Fish Oils - blood ; Fish Oils - therapeutic use ; Humans ; Interleukin-10 - blood ; Interleukin-17 - blood ; Interleukin-1beta - blood ; Life Sciences ; Lipidology ; Male ; Medical Biochemistry ; Medicinal Chemistry ; Microbial Genetics and Genomics ; Middle Aged ; Neurochemistry ; Nutrition ; Nutritional Status ; n‐3 Polyunsaturated fatty acids ; Original Article ; Polyunsaturated fatty acids ; Prognosis ; Prospective Studies ; Serum Albumin - metabolism ; Treatment Outcome ; Tumor Necrosis Factor-alpha - blood</subject><ispartof>Lipids, 2013-09, Vol.48 (9), p.879-888</ispartof><rights>AOCS 2013</rights><rights>2013 American Oil Chemists' Society (AOCS)</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4539-c4289f256914271319de1aa43a1a1dd8f68ff6308ff3bf089c7be927201043963</citedby><cites>FETCH-LOGICAL-c4539-c4289f256914271319de1aa43a1a1dd8f68ff6308ff3bf089c7be927201043963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11745-013-3816-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11745-013-3816-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,41464,42533,45550,45551,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23888317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mocellin, Michel Carlos</creatorcontrib><creatorcontrib>Pastore e Silva, Juliana de Aguiar</creatorcontrib><creatorcontrib>Camargo, Carolina de Quadros</creatorcontrib><creatorcontrib>Fabre, Maria Emília de Souza</creatorcontrib><creatorcontrib>Gevaerd, Scheila</creatorcontrib><creatorcontrib>Naliwaiko, Katya</creatorcontrib><creatorcontrib>Moreno, Yara Maria Franco</creatorcontrib><creatorcontrib>Nunes, Everson Araújo</creatorcontrib><creatorcontrib>Trindade, Erasmo Benicio Santos de Moraes</creatorcontrib><title>Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients</title><title>Lipids</title><addtitle>Lipids</addtitle><addtitle>Lipids</addtitle><description>Previous studies have shown that n-3 polyunsaturated fatty acids n-3 (n-3 PUFA) have several anticancer effects, especially attributed to their ability to modulate a variety of genomic and immune responses. In this context, this randomized, prospective, controlled clinical trial was conducted in order to check whether supplementation of 2 g/day of fish oil for 9 weeks alters the production of inflammatory markers, the plasma fatty acid profile and the nutritional status in patients with colorectal cancer (CRC). Eleven adults with CRC in chemotherapy were randomized into two groups: (a) supplemented (SG) daily with 2 g/day of encapsulated fish oil [providing 600 mg/day of eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)] for 9 weeks ( n  = 6), and (b) control (CG) ( n  = 5). All outcomes were evaluated on the day before the first chemotherapy session and 9 weeks later. Plasma TNF-α, IL-1β, IL-10 and IL-17A, the pro/anti-inflammatory balance (ratio TNF-α/IL-10 and IL-1β/IL10) and serum albumin, showed no significant changes between times and study groups ( p  &gt; 0.05). C-reactive protein (CRP) and the CRP/albumin ratio showed opposite behavior in groups, significantly reducing their values in SG ( p  &lt; 0.05). Plasma proportions of EPA and DHA increased 1.8 and 1.4 times, respectively, while the ARA reduced approximately 0.6 times with the supplementation (9 weeks vs baseline, p  &lt; 0.05). Patients from SG gained 1.2 kg (median) while the CG lost −0.5 kg (median) during the 9 weeks of chemotherapy ( p  = 0.72). These results demonstrate that 2 g/day of fish oil for 9 weeks of chemotherapy improves CRP values, CRP/albumin status, plasma fatty acid profile and potentially prevents weight loss during treatment.</description><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Body Mass Index</subject><subject>C-Reactive Protein - metabolism</subject><subject>Chemotherapy</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - blood</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Cytokines</subject><subject>Dietary Supplements</subject><subject>Docosahexaenoic Acids - administration &amp; dosage</subject><subject>Docosahexaenoic Acids - blood</subject><subject>Docosahexaenoic Acids - therapeutic use</subject><subject>Drug Administration Schedule</subject><subject>Eicosapentaenoic Acid - administration &amp; dosage</subject><subject>Eicosapentaenoic Acid - blood</subject><subject>Eicosapentaenoic Acid - therapeutic use</subject><subject>Fatty acid profile</subject><subject>Fatty Acids - blood</subject><subject>Female</subject><subject>Fish oil</subject><subject>Fish oils</subject><subject>Fish Oils - administration &amp; dosage</subject><subject>Fish Oils - blood</subject><subject>Fish Oils - therapeutic use</subject><subject>Humans</subject><subject>Interleukin-10 - blood</subject><subject>Interleukin-17 - blood</subject><subject>Interleukin-1beta - blood</subject><subject>Life Sciences</subject><subject>Lipidology</subject><subject>Male</subject><subject>Medical Biochemistry</subject><subject>Medicinal Chemistry</subject><subject>Microbial Genetics and Genomics</subject><subject>Middle Aged</subject><subject>Neurochemistry</subject><subject>Nutrition</subject><subject>Nutritional Status</subject><subject>n‐3 Polyunsaturated fatty acids</subject><subject>Original Article</subject><subject>Polyunsaturated fatty acids</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Serum Albumin - metabolism</subject><subject>Treatment Outcome</subject><subject>Tumor Necrosis Factor-alpha - blood</subject><issn>0024-4201</issn><issn>1558-9307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkcFu1DAQhi0EokvhAbggS1y4hHpiJ7aPq5SFlVZ0VcHZ8iaTxVXiFDtptU_RV66jFISQEJexbH__r5n5CXkL7CMwJi8igBRFxoBnXEGZsWdkBUWhMs2ZfE5WjOUiEzmDM_Iqxpt0BaGLl-Qs50opDnJFHjYu_qBXrqOXWAe0ESOtsmu09ejukO7DMKLzF-vuMPXO02s7uoFu-9sw3Dl_pF-nMbj05G03s0c_RBep9Q3ddzb2lm7sOJ7ounbN_N-6DmmyqYZuCFiPSVVZX2Og-2SMfoyvyYvWdhHfPJ3n5Pvm07fqS7a7-ryt1rusFgXXqeZKt3lRahC5BA66QbBWcAsWmka1pWrbkrNU-aFlStfygDqXaRdMcF3yc_Jh8U2T_JwwjqZ3scausx6HKRoQhSq4LCRL6Pu_0JthCmnimcpLobniPFGwUHUYYgzYmtvgehtOBpiZ0zJLWialZea0zOz87sl5OvTY_Fb8iicBcgHu0-JO_3c0u-3-kimpkzJflDGJ_BHDH03_s59HOV-vhA</recordid><startdate>201309</startdate><enddate>201309</enddate><creator>Mocellin, Michel Carlos</creator><creator>Pastore e Silva, Juliana de Aguiar</creator><creator>Camargo, Carolina de Quadros</creator><creator>Fabre, Maria Emília de Souza</creator><creator>Gevaerd, Scheila</creator><creator>Naliwaiko, Katya</creator><creator>Moreno, Yara Maria Franco</creator><creator>Nunes, Everson Araújo</creator><creator>Trindade, Erasmo Benicio Santos de Moraes</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>F1W</scope><scope>H95</scope><scope>L.G</scope></search><sort><creationdate>201309</creationdate><title>Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients</title><author>Mocellin, Michel Carlos ; Pastore e Silva, Juliana de Aguiar ; Camargo, Carolina de Quadros ; Fabre, Maria Emília de Souza ; Gevaerd, Scheila ; Naliwaiko, Katya ; Moreno, Yara Maria Franco ; Nunes, Everson Araújo ; Trindade, Erasmo Benicio Santos de Moraes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4539-c4289f256914271319de1aa43a1a1dd8f68ff6308ff3bf089c7be927201043963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Body Mass Index</topic><topic>C-Reactive Protein - metabolism</topic><topic>Chemotherapy</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - blood</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Cytokines</topic><topic>Dietary Supplements</topic><topic>Docosahexaenoic Acids - administration &amp; dosage</topic><topic>Docosahexaenoic Acids - blood</topic><topic>Docosahexaenoic Acids - therapeutic use</topic><topic>Drug Administration Schedule</topic><topic>Eicosapentaenoic Acid - administration &amp; dosage</topic><topic>Eicosapentaenoic Acid - blood</topic><topic>Eicosapentaenoic Acid - therapeutic use</topic><topic>Fatty acid profile</topic><topic>Fatty Acids - blood</topic><topic>Female</topic><topic>Fish oil</topic><topic>Fish oils</topic><topic>Fish Oils - administration &amp; dosage</topic><topic>Fish Oils - blood</topic><topic>Fish Oils - therapeutic use</topic><topic>Humans</topic><topic>Interleukin-10 - blood</topic><topic>Interleukin-17 - blood</topic><topic>Interleukin-1beta - blood</topic><topic>Life Sciences</topic><topic>Lipidology</topic><topic>Male</topic><topic>Medical Biochemistry</topic><topic>Medicinal Chemistry</topic><topic>Microbial Genetics and Genomics</topic><topic>Middle Aged</topic><topic>Neurochemistry</topic><topic>Nutrition</topic><topic>Nutritional Status</topic><topic>n‐3 Polyunsaturated fatty acids</topic><topic>Original Article</topic><topic>Polyunsaturated fatty acids</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Serum Albumin - metabolism</topic><topic>Treatment Outcome</topic><topic>Tumor Necrosis Factor-alpha - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mocellin, Michel Carlos</creatorcontrib><creatorcontrib>Pastore e Silva, Juliana de Aguiar</creatorcontrib><creatorcontrib>Camargo, Carolina de Quadros</creatorcontrib><creatorcontrib>Fabre, Maria Emília de Souza</creatorcontrib><creatorcontrib>Gevaerd, Scheila</creatorcontrib><creatorcontrib>Naliwaiko, Katya</creatorcontrib><creatorcontrib>Moreno, Yara Maria Franco</creatorcontrib><creatorcontrib>Nunes, Everson Araújo</creatorcontrib><creatorcontrib>Trindade, Erasmo Benicio Santos de Moraes</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><jtitle>Lipids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mocellin, Michel Carlos</au><au>Pastore e Silva, Juliana de Aguiar</au><au>Camargo, Carolina de Quadros</au><au>Fabre, Maria Emília de Souza</au><au>Gevaerd, Scheila</au><au>Naliwaiko, Katya</au><au>Moreno, Yara Maria Franco</au><au>Nunes, Everson Araújo</au><au>Trindade, Erasmo Benicio Santos de Moraes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients</atitle><jtitle>Lipids</jtitle><stitle>Lipids</stitle><addtitle>Lipids</addtitle><date>2013-09</date><risdate>2013</risdate><volume>48</volume><issue>9</issue><spage>879</spage><epage>888</epage><pages>879-888</pages><issn>0024-4201</issn><eissn>1558-9307</eissn><abstract>Previous studies have shown that n-3 polyunsaturated fatty acids n-3 (n-3 PUFA) have several anticancer effects, especially attributed to their ability to modulate a variety of genomic and immune responses. In this context, this randomized, prospective, controlled clinical trial was conducted in order to check whether supplementation of 2 g/day of fish oil for 9 weeks alters the production of inflammatory markers, the plasma fatty acid profile and the nutritional status in patients with colorectal cancer (CRC). Eleven adults with CRC in chemotherapy were randomized into two groups: (a) supplemented (SG) daily with 2 g/day of encapsulated fish oil [providing 600 mg/day of eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)] for 9 weeks ( n  = 6), and (b) control (CG) ( n  = 5). All outcomes were evaluated on the day before the first chemotherapy session and 9 weeks later. Plasma TNF-α, IL-1β, IL-10 and IL-17A, the pro/anti-inflammatory balance (ratio TNF-α/IL-10 and IL-1β/IL10) and serum albumin, showed no significant changes between times and study groups ( p  &gt; 0.05). C-reactive protein (CRP) and the CRP/albumin ratio showed opposite behavior in groups, significantly reducing their values in SG ( p  &lt; 0.05). Plasma proportions of EPA and DHA increased 1.8 and 1.4 times, respectively, while the ARA reduced approximately 0.6 times with the supplementation (9 weeks vs baseline, p  &lt; 0.05). Patients from SG gained 1.2 kg (median) while the CG lost −0.5 kg (median) during the 9 weeks of chemotherapy ( p  = 0.72). These results demonstrate that 2 g/day of fish oil for 9 weeks of chemotherapy improves CRP values, CRP/albumin status, plasma fatty acid profile and potentially prevents weight loss during treatment.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>23888317</pmid><doi>10.1007/s11745-013-3816-0</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-4201
ispartof Lipids, 2013-09, Vol.48 (9), p.879-888
issn 0024-4201
1558-9307
language eng
recordid cdi_proquest_miscellaneous_1458537570
source MEDLINE; Wiley Online Library Journals Frontfile Complete; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Animals
Biomedical and Life Sciences
Body Mass Index
C-Reactive Protein - metabolism
Chemotherapy
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - blood
Colorectal Neoplasms - drug therapy
Cytokines
Dietary Supplements
Docosahexaenoic Acids - administration & dosage
Docosahexaenoic Acids - blood
Docosahexaenoic Acids - therapeutic use
Drug Administration Schedule
Eicosapentaenoic Acid - administration & dosage
Eicosapentaenoic Acid - blood
Eicosapentaenoic Acid - therapeutic use
Fatty acid profile
Fatty Acids - blood
Female
Fish oil
Fish oils
Fish Oils - administration & dosage
Fish Oils - blood
Fish Oils - therapeutic use
Humans
Interleukin-10 - blood
Interleukin-17 - blood
Interleukin-1beta - blood
Life Sciences
Lipidology
Male
Medical Biochemistry
Medicinal Chemistry
Microbial Genetics and Genomics
Middle Aged
Neurochemistry
Nutrition
Nutritional Status
n‐3 Polyunsaturated fatty acids
Original Article
Polyunsaturated fatty acids
Prognosis
Prospective Studies
Serum Albumin - metabolism
Treatment Outcome
Tumor Necrosis Factor-alpha - blood
title Fish Oil Decreases C-Reactive Protein/Albumin Ratio Improving Nutritional Prognosis and Plasma Fatty Acid Profile in Colorectal Cancer Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A22%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fish%20Oil%20Decreases%20C-Reactive%20Protein/Albumin%20Ratio%20Improving%20Nutritional%20Prognosis%20and%20Plasma%20Fatty%20Acid%20Profile%20in%20Colorectal%20Cancer%20Patients&rft.jtitle=Lipids&rft.au=Mocellin,%20Michel%20Carlos&rft.date=2013-09&rft.volume=48&rft.issue=9&rft.spage=879&rft.epage=888&rft.pages=879-888&rft.issn=0024-4201&rft.eissn=1558-9307&rft_id=info:doi/10.1007/s11745-013-3816-0&rft_dat=%3Cproquest_cross%3E3050043621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1426493833&rft_id=info:pmid/23888317&rfr_iscdi=true